What companies are participating in the DAPT Study?
A group of drug-eluting stent and antiplatelet therapy manufacturers are collaborating with the Harvard Clinical Research Institute and providing funding for the DAPT Study (in alphabetical order): Abbott, Boston Scientific Corporation, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Cordis Corporation, Eli Lilly and Company and Daiichi Sankyo Company Limited, and Medtronic, Inc.
Related Questions
- What other dual antiplatelet therapy duration trials are being conducted? How is the DAPT Study different from the others?
- Which Dutch companies would be interested in in a study on change project portfolio governance and director motivation?
- Does the Control Premium Study include transactions of privately held companies?